References
- European Commission. European semester-thematic factsheet. Women in the labour market. Accessed November 19, 2024. Available from: https://commission.europa.eu/document/download/b90d3b1f-870d-461c-9352-fec4bdf7e0cc_ro?filename=european-semester_thematic-factsheet_labour-force-participation-women_ro.pdf
- ORDIN 5707 01/08/2024 - Portal Legislativ. Accessed November 19, 2024. https://legislatie.just.ro/Public/DetaliiDocument/286827
- OUG 96 14/10/2003 - Portal Legislativ. Accessed November 18, 2024. https://legislatie.just.ro/Public/DetaliiDocument/47216
- Substanțe per- și polifluoroalchilice (PFAS) - ECHA. Accessed November 19, 2024. https://poisoncentres.echa.europa.eu/ro/web/guest/hot-topics/perfluoroalkyl-chemicals-pfas
- OECD Global Forum on the Environment dedicated to Per- and Polyfluoroalkyl Substances (PFAS). Accessed November 19, 2024. Available from: https://www.oecd.org/content/dam/oecd/en/topics/policy-sub-issues/risk-management-risk-reduction-and-sustainable-chemistry2/events/pfas-gfe-2024/global-forum-on-environment-work-on-pfass.pdf
- Jurnalul Oficial al Uniunii Europene. Regulamentul delegat (UE) 2020/784 al Comisiei din 8 aprilie 2020 de modificare a anexei I la Regulamentul (UE) 2019/1021 al Parlamentului European și al Consiliului în ceea ce privește includerea acidului perfluorooctanoic (PFOA), a sărurilor acestuia și a compușilor înrudiți cu acesta. Accessed November 19, 2024. Available from: https://eur-lex.europa.eu/legal-content/RO/TXT/PDF/?uri=CELEX:32020R0784&from=EN
- IARC Monographs evaluate the carcinogenicity of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS). Accessed November 19, 2024. Available from: https://www.iarc.who.int/news-events/iarc-monographs-evaluate-the-carcinogenicity-of-perfluorooctanoic-acid-pfoa-and-perfluorooctanesulfonic-acid-pfos
- Substanțe per- și polifluoroalchilice (PFAS) - ECHA. Accessed November 19, 2024. https://echa.europa.eu/ro/hot-topics/perfluoroalkyl-chemicals-pfas
- Jurnalul Oficial al Uniunii Europene. Recomandarea (UE) 2022/1431 a Comisiei din 24 august 2022 privind monitorizarea substanțelor perfluoroalchilate din alimente. Accessed November 19, 2024. Available from: https://eur-lex.europa.eu/legal-content/RO/TXT/HTML/?uri=CELEX%3A32022H1431
- Andersen ME, Butenhoff JL, Chang SC, et al. Perfluoroalkyl Acids and Related Chemistries—Toxicokinetics and Modes of Action. Toxicol Sci. 2008;102(1):3–14. doi:10.1093/toxsci/kfm270
- Stein CR, Wolff MS, Calafat AM, Kato K, Engel SM. Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: A pilot study. Reprod Toxicol. 2012;34(3):312–316. doi:10.1016/j.reprotox.2012.05.039
- Southern Research Institute. Protein Binding of Perfluorohexane Sulfonate, Perfiuorooctane Sulfonate and Perfluorooctanoate to Plasma (Human, Rat, and Monkey), and Various Human-Derived Plasma Protein Fractions. Study ID : 9921.7. Accessed November 20, 2024. Available from: https://cdn.toxicdocs.org/b5/b5GdBBdrX7baRpmeapLREKOq6/b5GdBBdrX7baRpmeapLREKOq6.pdf
- Zhang X, Chen L, Fei XC, Ma YS, Gao HW. Binding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals. BMC Mol Biol. 2009;10:16. doi:10.1186/1471-2199-10-16
- Chen YM, Guo LH. Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin. Arch Toxicol. 2009;83(3):255–261. doi:10.1007/s00204-008-0359-x
- Weiss JM, Andersson PL, Lamoree MH, Leonards PEG, van Leeuwen SPJ, Hamers T. Competitive Binding of Poly- and Perfluorinated Compounds to the Thyroid Hormone Transport Protein Transthyretin. Toxicol Sci. 2009;109(2):206–216. doi:10.1093/toxsci/kfp055
- EPA. Health Effects Support Document for Perfluorooctane Sulfonate (PFOS). Available from: https://epa.gov/sites/default/files/2016-05/documents/pfos_hesd_final_508.pdf
- Olsen GW, Burris JM, Ehresman DJ, et al. Half-Life of Serum Elimination of Perfluorooctanesulfonate, Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers. Environ Health Perspect. 2007;115(9):1298–1305. doi:10.1289/ehp.10009
- Li Y, Fletcher T, Mucs D, et al. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. Occup Environ Med. 2018;75(1):46–51. doi:10.1136/oemed-2017-104651
- Zhou W, Zhang L, Tong C, et al. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women. Environ Health Perspect. 2017;125(6):067012. doi:10.1289/EHP1203
- Ding N, Harlow SD, John F Randolph J, et al. Associations of Perfluoroalkyl Substances with Incident Natural Menopause: The Study of Women’s Health Across the Nation. J Clin Endocrinol Metab. 2020;105(9):e3169. doi:10.1210/clinem/dgaa303
- Han X, Snow TA, Kemper RA, Jepson GW. Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol. 2003;16(6):775–781. doi:10.1021/tx034005w
- Park SK, Peng Q, Ding N, Mukherjee B, Harlow SD. Determinants of per- and polyfluoroalkyl substances (PFAS) in midlife women: Evidence of racial/ethnic and geographic differences in PFAS exposure. Environ Res. 2019;175:186–199. doi:10.1016/j.envres.2019.05.028
- Rickard BP, Rizvi I, Fenton SE. Per- and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease. Toxicology. 2022;465:153031. doi:10.1016/j.tox.2021.153031
- Sagiv SK, Rifas-Shiman SL, Webster TF, et al. Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations. Environ Sci Technol. 2015;49(19):11849. doi:10.1021/acs.est.5b02489
- Fromme H, Mosch C, Morovitz M, et al. Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol. 2010;44(18):7123–7129. doi:10.1021/es101184f
- Caban-Martinez AJ, Solle NS, Feliciano PL, et al. Use of Aqueous Film-Forming Foams and Knowledge of Perfluorinated Compounds among Florida Firefighters. J Occup Environ Med. 2019;61(5):e227. doi:10.1097/JOM.0000000000001566
- Freberg BI, Haug LS, Olsen R, et al. Occupational exposure to airborne perfluorinated compounds during professional ski waxing. Environ Sci Technol. 2010;44(19):7723–7728. doi:10.1021/es102033k
- Lundin JI, Alexander BH, Olsen GW, Church TR. Ammonium perfluorooctanoate production and occupational mortality. Epidemiol Camb Mass. 2009;20(6):921–928. doi:10.1097/EDE.0b013e3181b5f395
- Heydebreck F, Tang J, Xie Z, Ebinghaus R. Emissions of Per- and Polyfluoroalkyl Substances in a Textile Manufacturing Plant in China and Their Relevance for Workers’ Exposure. Environ Sci Technol. 2016;50(19):10386–10396. doi:10.1021/acs.est.6b03213
- PFAS Health Study Systematic Review_1.pdf. Accessed November 19, 2024. https://nceph.anu.edu.au/files/PFAS%20Health%20Study%20Systematic%20Review_1.pdf
- Panieri E, Baralic K, Djukic-Cosic D, Djordjevic AB, Saso L. PFAS Molecules: A Major Concern for the Human Health and the Environment. Toxics. 2022;10(2):44. doi:10.3390/toxics10020044
- Sunderland EM, Hu XC, Dassuncao C, Tokranov AK, Wagner CC, Allen JG. A Review of the Pathways of Human Exposure to Poly- and Perfluoroalkyl Substances (PFASs) and Present Understanding of Health Effects. J Expo Sci Environ Epidemiol. 2018;29(2):131. doi:10.1038/s41370-018-0094-1
- Zoeller RT, Brown TR, Doan LL, et al. Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society. Endocrinology. 2012;153(9):4097. doi:10.1210/en.2012-1422
- Gore AC, Chappell VA, Fenton SE, et al. EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015;36(6):E1. doi:10.1210/er.2015-1010
- Mattsson K, Nilsson-Condori E, Elmerstig E, et al. Fertility outcomes in women with pre-existing type 2 diabetes—a prospective cohort study. Fertil Steril. 2021;116(2):505–513. doi:10.1016/j.fertnstert.2021.02.009
- Thong EP, Codner E, Laven JSE, Teede H. Diabetes: a metabolic and reproductive disorder in women. Lancet Diabetes Endocrinol. 2020;8(2):134–149. doi:10.1016/S2213-8587(19)30345-6
- Ding GL, Liu Y, Liu ME, et al. The effects of diabetes on male fertility and epigenetic regulation during spermatogenesis. Asian J Androl. 2015;17(6):948. doi:10.4103/1008-682X.150844
- Alexopoulos AS, Blair R, Peters AL. Management of preexisting diabetes in pregnancy: A Review. JAMA. 2019;321(18):1811. doi:10.1001/jama.2019.4981
- Mulder JW, Kusters DM, Lennep JER van, Hutten BA. Lipid metabolism during pregnancy: consequences for mother and child. Curr Opin Lipidol. 2024;35(3):133. doi:10.1097/MOL.0000000000000927
- Barrett ES, Chen C, Thurston SW, et al. Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women. Fertil Steril. 2015;103(5):1261–1270.e3. doi:10.1016/j.fertnstert.2015.02.001
- Behr AC, Lichtenstein D, Braeuning A, Lampen A, Buhrke T. Perfluoroalkylated substances (PFAS) affect neither estrogen and androgen receptor activity nor steroidogenesis in human cells in vitro. Toxicol Lett. 2018;291:51–60. doi:10.1016/j.toxlet.2018.03.029
- Feng X, Wang X, Cao X, Xia Y, Zhou R, Chen L. Chronic Exposure of Female Mice to an Environmental Level of Perfluorooctane Sulfonate Suppresses Estrogen Synthesis Through Reduced Histone H3K14 Acetylation of the StAR Promoter Leading to Deficits in Follicular Development and Ovulation. Toxicol Sci Off J Soc Toxicol. 2015;148(2):368–379. doi:10.1093/toxsci/kfv197
- Nian M, Luo K, Luo F, et al. Association between Prenatal Exposure to PFAS and Fetal Sex Hormones: Are the Short-Chain PFAS Safer? Environ Sci Technol. 2020;54(13):8291–8299. doi:10.1021/acs.est.0c02444
- Rashtian J, Chavkin DE, Merhi Z. Water and soil pollution as determinant of water and food quality/contamination and its impact on female fertility. Reprod Biol Endocrinol RBE. 2019;17:5. doi:10.1186/s12958-018-0448-5
- Shi Z, Zhang H, Ding L, Feng Y, Xu M, Dai J. The effect of perfluorododecanonic acid on endocrine status, sex hormones and expression of steroidogenic genes in pubertal female rats. Reprod Toxicol. 2009;27(3):352–359. doi:10.1016/j.reprotox.2009.02.008
- Vélez MP, Arbuckle TE, Fraser WD. Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study. Hum Reprod Oxf Engl. 2015;30(3):701. doi:10.1093/humrep/deu350
- Shen J, Mao Y, Zhang H, et al. Exposure of women undergoing in-vitro fertilization to per-and polyfluoroalkyl substances: Evidence on negative effects on fertilization and high-quality embryos. Environ Pollut. 2024;359:124474. doi:10.1016/j.envpol.2024.124474
- Du G, Hu J, Huang Z, et al. Neonatal and juvenile exposure to perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS): Advance puberty onset and kisspeptin system disturbance in female rats. Ecotoxicol Environ Saf. 2019;167:412–421. doi:10.1016/j.ecoenv.2018.10.025
- Vélez MP, Arbuckle TE, Fraser WD. Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study. Hum Reprod Oxf Engl. 2015;30(3):701. doi:10.1093/humrep/deu350
- Zhang S, Tan R, Pan R, et al. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women. J Clin Endocrinol Metab. 2018;103(7):2543–2551. doi:10.1210/jc.2017-02783
- Liew Z, Luo J, Nohr EA, et al. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case–Control Study in the Danish National Birth Cohort. Environ Health Perspect. 2020;128(4):047007. doi:10.1289/EHP6202
- Blake BE, Fenton SE. Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects. Toxicology. 2020;443:152565. doi:10.1016/j.tox.2020.152565
- Zhang N, Wang WS, Li WJ, Liu C, Wang Y, Sun K. Reduction of progesterone, estradiol and hCG secretion by perfluorooctane sulfonate via induction of apoptosis in human placental syncytiotrophoblasts. Placenta. 2015;36(5):575–580. doi:10.1016/j.placenta.2015.02.008
- Everson TM, Sehgal N, Barr DB, et al. Placental PFAS concentrations are associated with perturbations of placental DNA methylation at loci with important roles on cardiometabolic health. medRxiv. Published online May 7, 2024:2024.05.06.24306905. doi:10.1101/2024.05.06.24306905
- Groisman L, Berman T, Quinn A, et al. Levels of PFAS concentrations in the placenta and pregnancy complications. Ecotoxicol Environ Saf. 2023;262:115165. doi:10.1016/j.ecoenv.2023.115165
- Aimuzi R, Luo K, Huang R, et al. Perfluoroalkyl and polyfluroalkyl substances and maternal thyroid hormones in early pregnancy. Environ Pollut. 2020;264:114557. doi:10.1016/j.envpol.2020.114557
- Blake BE, Pinney SM, Hines EP, Fenton SE, Ferguson KK. Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort. Environ Pollut. 2018;242:894–904. doi:10.1016/j.envpol.2018.07.042
- Singh R. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology. Published online January 1, 2008. Accessed November 19, 2024. Available from: https://www.academia.edu/14796429/Thyroid_hormone_status_and_pituitary_function_in_adult_rats_given_oral_doses_of_perfluorooctanesulfonate_PFOS_
- Fenton SE, Ducatman A, Boobis A, et al. Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research. Environ Toxicol Chem. 2021;40(3):606–630. doi:10.1002/etc.4890
- Jain RB. Association between thyroid profile and perfluoroalkyl acids: Data from NHNAES 2007–2008. Environ Res. 2013;126:51–59. doi:10.1016/j.envres.2013.08.006
- Lau C, Thibodeaux JR, Hanson RG, et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci Off J Soc Toxicol. 2003;74(2):382–392. doi:10.1093/toxsci/kfg122
- Lewis RC, Johns LE, Meeker JD. Serum Biomarkers of Exposure to Perfluoroalkyl Substances in Relation to Serum Testosterone and Measures of Thyroid Function among Adults and Adolescents from NHANES 2011–2012. Int J Environ Res Public Health. 2015;12(6):6098–6114. doi:10.3390/ijerph120606098
- Wang Y, Rogan WJ, Chen PC, et al. Association between Maternal Serum Perfluoroalkyl Substances during Pregnancy and Maternal and Cord Thyroid Hormones: Taiwan Maternal and Infant Cohort Study. Environ Health Perspect. 2014;122(5):529–534. doi:10.1289/ehp.1306925
- Herwig A, Campbell G, Mayer CD, et al. A thyroid hormone challenge in hypothyroid rats identifies T3 regulated genes in the hypothalamus and in models with altered energy balance and glucose homeostasis. Thyroid Off J Am Thyroid Assoc. 2014;24(11):1575–1593. doi:10.1089/thy.2014.0169
- Zhang C, Guo L, Zhu B, et al. Effects of 3, 5, 3’-triiodothyronine (t3) and follicle stimulating hormone on apoptosis and proliferation of rat ovarian granulosa cells. Chin J Physiol. 2013;56(5):298–305. doi:10.4077/CJP.2013.BAB186
- Kirkland JL, Gardner RM, Mukku VR, Akhtar M, Stancel GM. Hormonal control of uterine growth: the effect of hypothyroidism on estrogen-stimulated cell division. Endocrinology. 1981;108(6):2346–2351. doi:10.1210/endo-108-6-2346
- Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol (Oxf). 2007;66(3):309–321. doi:10.1111/j.1365-2265.2007.02752.x
- Shi W, Zhang Z, Li M, Dong H, Li J. Reproductive toxicity of PFOA, PFOS and their substitutes: A review based on epidemiological and toxicological evidence. Environ Res. 2024;250:118485. doi:10.1016/j.envres.2024.118485
- Di Nisio A, Sabovic I, Valente U, et al. Endocrine Disruption of Androgenic Activity by Perfluoroalkyl Substances: Clinical and Experimental Evidence. J Clin Endocrinol Metab. 2019;104(4):1259–1271. doi:10.1210/jc.2018-01855
- Timmermann CAG, Budtz-Jørgensen E, Petersen MS, et al. Shorter duration of breastfeeding at elevated exposures to perfluoroalkyl substances. Reprod Toxicol. 2017;68:164–170. doi:10.1016/j.reprotox.2016.07.010
- Rosen EM, Brantsæter AL, Carroll R, et al. Maternal Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Breastfeeding Duration in the Norwegian Mother and Child Cohort. Environ Epidemiol Phila Pa. 2018;2(3):e027. doi:10.1097/EE9.0000000000000027
- Mamsen LS, Björvang RD, Mucs D, et al. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies. Environ Int. 2019;124:482–492. doi:10.1016/j.envint.2019.01.010
- Varsi K, Torsvik IK, Huber S, Averina M, Brox J, Bjørke-Monsen AL. Impaired gross motor development in infants with higher PFAS concentrations. Environ Res. 2022;204:112392. doi:10.1016/j.envres.2021.112392
- Fei C, McLaughlin JK, Tarone RE, Olsen J. Perfluorinated Chemicals and Fetal Growth: A Study within the Danish National Birth Cohort. Environ Health Perspect. 2007;115(11):1677–1682. doi:10.1289/ehp.10506
- Zheng T, Kelsey K, Zhu C, et al. Adverse birth outcomes related to concentrations of per- and polyfluoroalkyl substances (PFAS) in maternal blood collected from pregnant women in 1960–1966. Environ Res. 2024;241:117010. doi:10.1016/j.envres.2023.117010
- Assessment UENC for E. Birth outcomes in relation to prenatal exposure to per- and polyfluoroalkyl substances and stress in the environmental influences on child health outcomes (echo) program. March 15, 2009. Accessed November 19, 2024. https://hero.epa.gov/hero/index.cfm/reference/details/reference_id/10893257
- Lamichhane S, Siljander H, Duberg D, et al. Exposure to per- and polyfluoroalkyl substances associates with an altered lipid composition of breast milk. Environ Int. 2021;157:106855. doi:10.1016/j.envint.2021.106855
- Varsi K, Torsvik IK, Huber S, Averina M, Brox J, Bjørke-Monsen AL. Impaired gross motor development in infants with higher PFAS concentrations. Environ Res. 2022;204:112392. doi:10.1016/j.envres.2021.112392
- Varsi K, Torsvik IK, Huber S, Averina M, Brox J, Bjørke-Monsen AL. Impaired gross motor development in infants with higher PFAS concentrations. Environ Res. 2022;204:112392. doi:10.1016/j.envres.2021.112392
- Frangione B, Birk S, Benzouak T, et al. Exposure to perfluoroalkyl and polyfluoroalkyl substances and pediatric obesity: a systematic review and meta-analysis. Int J Obes 2005. 2024;48(2):131–146. doi:10.1038/s41366-023-01401-6
- Geiger SD, Yao P, Vaughn MG, Qian Z. PFAS exposure and overweight/obesity among children in a nationally representative sample. Chemosphere. 2021;268:128852. doi:10.1016/j.chemosphere.2020.128852
- Lauritzen HB, Larose TL, Øien T, et al. Prenatal exposure to persistent organic pollutants and child overweight/obesity at 5-year follow-up: a prospective cohort study. Environ Health. 2018;17:9. doi:10.1186/s12940-017-0338-x
- Beck IH, Bilenberg N, Möller S, et al. Association Between Prenatal and Early Postnatal Exposure to Perfluoroalkyl Substances and IQ Score in 7-Year-Old Children From the Odense Child Cohort. Am J Epidemiol. 2023;192(9):1522–1535. doi:10.1093/aje/kwad110
- Spratlen MJ, Perera FP, Lederman SA, et al. The association between prenatal exposure to perfluoroalkyl substances and childhood neurodevelopment. Environ Pollut. 2020;263:114444. doi:10.1016/j.envpol.2020.114444
- Ernst A, Brix N, Lauridsen LLB, et al. Exposure to Perfluoroalkyl Substances during Fetal Life and Pubertal Development in Boys and Girls from the Danish National Birth Cohort. Environ Health Perspect. 2019;127(1):017004. doi:10.1289/EHP3567
- Kristensen SL, Ramlau-Hansen CH, Ernst E, et al. Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction. Hum Reprod Oxf Engl. 2013;28(12):3337–3348. doi:10.1093/humrep/det382
- Lopez-Espinosa MJ, Fletcher T, Armstrong B, et al. Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ Sci Technol. 2011;45(19):8160–8166. doi:10.1021/es1038694
- Marks KJ, Howards PP, Smarr MM, et al. Prenatal exposure to mixtures of persistent endocrine disrupting chemicals and early menarche in a population-based cohort of British girls. Environ Pollut. 2021;276:116705. doi:10.1016/j.envpol.2021.116705
- Zahm S, Bonde JP, Chiu WA, et al. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. Lancet Oncol. 2024;25(1):16–17. doi:10.1016/S1470-2045(23)00622-8
- Jones RR, Madrigal JM, Troisi R, et al. Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia. J Natl Cancer Inst. 2024;116(5):728–736. doi:10.1093/jnci/djad261
- Hærvig KK, Petersen KU, Hougaard KS, et al. Maternal Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Male Reproductive Function in Young Adulthood: Combined Exposure to Seven PFAS. Environ Health Perspect. 2022;130(10):107001. doi:10.1289/EHP10285
- Cohn BA, La Merrill MA, Krigbaum NY, et al. In utero exposure to poly− and perfluoroalkyl substances (PFASs) and subsequent breast cancer. Reprod Toxicol. 2020;92:112–119. doi:10.1016/j.reprotox.2019.06.012
- Blake BE, Pinney SM, Hines EP, Fenton SE, Ferguson KK. Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort. Environ Pollut. 2018;242:894–904. doi:10.1016/j.envpol.2018.07.042
- Cardenas A, Hauser R, Gold DR, et al. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity. JAMA Netw Open. 2018;1(4):e181493. doi:10.1001/jamanetworkopen.2018.1493
- Hölzer J, Midasch O, Rauchfuss K, et al. Biomonitoring of Perfluorinated Compounds in Children and Adults Exposed to Perfluorooctanoate-Contaminated Drinking Water. Environ Health Perspect. 2008;116(5):651–657. doi:10.1289/ehp.11064
- Ding N, Karvonen-Gutierrez CA, Herman WH, Calafat AM, Mukherjee B, Park SK. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women. Int J Hyg Environ Health. 2021;235:113777. doi:10.1016/j.ijheh.2021.113777
- Wu B, Pan Y, Li Z, et al. Serum per- and polyfluoroalkyl substances and abnormal lipid metabolism: A nationally representative cross-sectional study. Environ Int. 2023;172:107779. doi:10.1016/j.envint.2023.107779
- Chen Z, Yang T, Walker DI, et al. Dysregulated lipid and fatty acid metabolism link perfluoroalkyl substances exposure and impaired glucose metabolism in young adults. Environ Int. 2020;145:106091. doi:10.1016/j.envint.2020.106091
- Jiang L, Liu Y, Zhou Y, et al. Targeted metabolomics unravels altered phenylalanine levels in piglets receiving total parenteral nutrition. FASEB J Off Publ Fed Am Soc Exp Biol. 2023;37(7):e23014. doi:10.1096/fj.202300261RR
- Rotander A, Ramos MJG, Mueller JF, Toms LM, Hyötyläinen T. Metabolic changes associated with PFAS exposure in firefighters: A pilot study. Sci Total Environ. 2024;953:176004. doi:10.1016/j.scitotenv.2024.176004
- Lundin JI, Alexander BH, Olsen GW, Church TR. Ammonium Perfluorooctanoate Production and Occupational Mortality. Epidemiology. 2009;20(6):921. doi:10.1097/EDE.0b013e3181b5f395
- Leonard RC, Kreckmann KH, Sakr CJ, Symons JM. Retrospective Cohort Mortality Study of Workers in a Polymer Production Plant Including a Reference Population of Regional Workers. Ann Epidemiol. 2008;18(1):15–22. doi:10.1016/j.annepidem.2007.06.011
- Cardenas A, Hivert MF, Gold DR, et al. Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease. Diabetes Care. 2019;42(9):1824–1832. doi:10.2337/dc18-2254
- Domazet SL, Grøntved A, Timmermann AG, Nielsen F, Jensen TK. Longitudinal Associations of Exposure to Perfluoroalkylated Substances in Childhood and Adolescence and Indicators of Adiposity and Glucose Metabolism 6 and 12 Years Later: The European Youth Heart Study. Diabetes Care. 2016;39(10):1745–1751. doi:10.2337/dc16-0269
- Meyer JD, McDiarmid M, Diaz JH, Baker BA, Hieb M, Toxicology ATF on R. Reproductive and Developmental Hazard Management. J Occup Environ Med. 2016;58(3):e94. doi:10.1097/JOM.0000000000000669